By enhancing the antioxidant defenses of cancer cells and promoting survival pathways, HO-1 helps to protect PC cells from the cytotoxic effects of these treatments, thereby contributing to therapy resistance and disease progression. The gene discussed is HMOX1; the disease is cancer.